COL4A1 Mutation in a Neonate With Intrauterine Stroke and Anterior Segment Dysgenesis

Shaheen Durrani-Kolarik1, Kandamurugu Manickam2, Bernadette Chen3

  • 1Nationwide Children's Hospital, Columbus, Ohio.

Pediatric Neurology
|January 4, 2017
PubMed

Insights

A de novo mutation in COL4A1, a gene encoding type IV collagen, was identified in an infant with severe neurological and ocular abnormalities. This finding is crucial for managing affected newborns and guiding genetic counseling.

Area of Science:

  • Genetics
  • Molecular Biology
  • Developmental Biology

Background:

  • COL4A1 gene encodes alpha 1 chain of type IV collagen, essential for basal membranes.
  • COL4A1 mutations can lead to severe conditions affecting brain, eyes, and vasculature.
  • Expression is prominent in brain, muscles, kidneys, and eyes.

Observation:

  • A term infant presented with encephalomalacia and intrauterine stroke.
  • The infant also exhibited anterior segment dysgenesis, a developmental disorder of the eye.
  • A de novo mutation in the COL4A1 gene was identified in this patient.

Findings:

  • The identified de novo COL4A1 mutation is linked to severe neonatal neurological and ocular phenotypes.
  • This mutation disrupts the function of type IV collagen, impacting basal membrane integrity.
  • The case highlights the phenotypic variability and severity associated with COL4A1 mutations.

Implications:

  • Genetic identification of COL4A1 mutations aids in accurate diagnosis of affected neonates.
  • Understanding the mutation's impact is vital for perinatal management strategies.
  • Genetic counseling for families with COL4A1 mutations can be informed by this case.
Abstract